Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort Study
Barr, Elizabeth L.M., Barzi, Federica, Mills, Phillip, Nickels, Maria, Graham, Sian, Pearson, Odette, Obeyesekere, Varuni, Hoy, Wendy E., Jones, Graham R.D., Lawton, Paul D., Brown, Alex D.H., Thomas, Mark, Sinha, Ashim, Cass, Alan, MacIsaac, Richard J., Maple-Brown, Louise J., and Hughes, Jaquelyne T. (2025) Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort Study. Canadian Journal of Kidney Health and Disease, 12. pp. 1-11.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (715kB) | Preview |
Abstract
Background: Traditional markers modestly predict chronic kidney disease progression in Aboriginal and Torres Strait Islander people. Therefore, we assessed associations of cardiometabolic and inflammatory clinical biomarkers with kidney disease progression among Aboriginal and Torres Strait Islander people with and without diabetes. Objectives: To identify cardiometabolic and inflammatory clinical biomarkers that predict kidney disease progression in Aboriginal and Torres Strait Islander people. Design: Prospective observational cohort study Setting: Northern Territory, Australia Participants: Aboriginal and Torres Strait Islander participants of the estimated glomerular filtration rate (eGFR) study with (n = 218) and without diabetes (n = 278) Measurements: Baseline biomarkers (expressed as 1 standard deviation increase in logarithmic scale), plasma kidney injury molecule-1 (pKIM-1) (pg/ml), high-sensitivity troponin-T (hs-TnT) (ng/L), troponin-I (hs-TnI) (ng/L), and soluble tumor necrosis factor receptor-1 (sTNFR-1) (pg/ml) were assessed in 496 adults. Annual change in eGFR (ml/min/1.73 m<sup>2</sup>) and a composite kidney outcome (first of ≥30% eGFR decline with follow-up eGFR <60 ml/min/1.73 m<sup>2</sup>, initiation of kidney replacement therapy or kidney disease-related death) over a median of 3 years. Methods: Linear regression estimated annual change in eGFR (ml/min/1.73 m<sup>2</sup>). Cox proportional hazards regression estimated hazard ratio (HR) and 95% CI for developing a combined kidney health outcome. Results: In individuals with diabetes, but not those without diabetes, higher baseline hs-TnT (−2.1 [−4.1 to −0.2], P = .033) and sTNFR-1 (−1.8 [−3.5 to −0.1], P = .039) predicted mean (95% CI) eGFR change, after adjusting for age, gender, baseline eGFR, and urinary albumin-to-creatinine ratio. Baseline variables explained 11% of eGFR decline variance; increasing to 27% (P < .001) with biomarkers. In diabetes, hs-TnT and hs-TnI were significantly associated with increased risk of kidney health outcomes. Limitations: Limitations included potential chronic kidney disease misclassification from single creatinine and albumin measurements, limited adjustment for covariates due to a small sample size, and short follow-up restricting long-term outcome assessment. Conclusions: Cardiovascular, kidney, and inflammatory biomarkers are likely associated with kidney function loss in diabetes, with particularly prominent associations for cardiac injury markers.
| Item ID: | 90662 |
|---|---|
| Item Type: | Article (Research - C1) |
| ISSN: | 2054-3581 |
| Keywords: | epidemiology, First Nations, inflammatory markers, kidney disease progression, novel biomarkers |
| Copyright Information: | © The Author(s) 2025. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| Funders: | National Health and Medical Research Council (NHMRC) |
| Projects and Grants: | NHMRC 545202, NHMRC 1021460, NHMRC GNT1184083, NHMRC 631947, NHMRC 605837, NHMRC 1078477, NHMRC 1194698, NHMRC GNT2026852, NHMRC 631947, NHMRC 1092576, NHMRC 1174758, NHMRC 1038721, NHMRC 1120640, NHMRC 1079502, NHMRC 44126324, NHMRC 1194677 |
| Date Deposited: | 13 Nov 2026 06:18 |
| FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320214 Nephrology and urology @ 100% |
| SEO Codes: | 20 HEALTH > 2001 Clinical health > 200101 Diagnosis of human diseases and conditions @ 100% |
| Downloads: |
Total: 1 Last 12 Months: 1 |
| More Statistics |
